Zusammenfassung
Antikörper gegen Zellkerne, glatte Muskulatur und Mitochondrien lassen sich bei der primären biliären Lebercirrhose, der chronisch aktiven Hepatitis und Fällen von kryptogener Lebercirrhose nachweisen.
Mitochondriale Antikörper kommen bei der biliären Cirrhose in etwa 90% der Fälle vor, bei den beiden anderen Krankheiten in etwa 24–26%.
Die pathogenetische Rolle dieser organunspezifischen und heterologen Antikörper ist nicht geklärt. Ihr Nachweis hat differentialdiagnostische Bedeutung, da Seren von Patienten mit extrahepatischem Ikterus, sekundärer Lebercirrhose oder einer akuten Virus-Hepatitis nicht oder nur niedertitrig mit diesen Antigenen in der Immunofluorescenz reagieren.
Die bei der primären biliären Lebercirrhose vorkommenden mitochondrialen Autoantikörper sind mit einem Antigen innerer mitochondrialer Membranen assoziiert. Leicht extrahierbare Membranproteine und die Enzyme der Elektronentransportkette sind an der immunologischen Reaktion nicht beteiligt. Das membrangebundene Antigen ist ein Lipoprotein und könnte mit Transportproteinen, die auch von Bakterien-Membranen bekannt sind, im Zusammenhang gebracht werden. Die Entstehung dieser Antikörper als Folge einer Kreuzreaktion mit Membranenzymen bestimmter Mikroorganismen ist deshalb nicht auszuschließen.
Summary
Tissue antibodies against nuclei, smooth muscles and mitochondria are very largely confined to three recognised liver diseases: primary biliary cirrhosis (PBC), activ chronic hepatitis and cryptogenic cirrhosis.
Mitochondrial antibodies occur in about 90% of patients with PBC and in 24–26% of patients with the two other liver diseases.
Their role in the pathogenesis of these disorders is still undefined, but it is of diagnostic importance that these tissue antibodies are not found in cirrhosis due to known insults — e.g., alcoholism, Wilson's disease and haemochrommatosis—or in the different forms of secondary biliary cirrhosis, related to main duct obstruction, congenital atresia or sclerosing cholangitis.
The autoantibodies found in sera of patients with primary biliary cirrhosis have been shown to react with a component of the mitochondrial inner membranes. The enzymes of the electron transport chain and a number of readily extractable mitochondrial proteins were not associated with the membrane fragment containing the antigen. There is some evidence that the antigen, which is a lipoprotein, may be a membrane-transport-protein.
Since inner membranes have structural similarities with the coat of some viruses or bacteria the formation of mitochondrial antibodies due to cross reaction with as yet unidentified microorganisms cannot be excluded.
Literatur
Asherson, G. L.: Autoantibodies against nuclear and cytoplasmic cell constituents in systemic lupus crythematosus and other diseases. Brit. J. exp. Path.40, 209 (1959).
——, and D. C. Dumonde: Autoantibody production in rabbits. II. Organ-specific autoantibodies in rabbits injected with rat tissue. Immunology6, 19 (1963).
Bardhan, K. D., J. R. Hall, G. H. Spray, and S. T. E. Callender: Blocking and binding autoantibody to intrinsic factor. Lancet1968 I, 62.
Beall, G. N., and S. H. Ohanian: The nature of complement-fixing antigen in normal human liver extracts. J. Lab. clin. Med.61, 67 (1963).
Bearn, A. G., H. G. Kunkel, and R. J. Slater: The problem of chronic liver disease in young women. Amer. J. Med.21, 3 (1956).
Begemann, H., and H. G. Harwerth: Praktische Hämatologie, 4. Aufl., S. 93, 170. Stuttgart: Georg Thieme 1969.
Berg, P. A., D. Doniach, and I. M. Roitt: Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes. J. exp. Med.126, 277 (1967).
——, U. Muscatello, R. W. Horne, I. M. Roitt, and D. Doniach: Mitochondrial antibodies in primary biliary cirrhosis. II. The complement fixing antigen as a component of mitochondrial inner membranes. Brit. J. exp. Path.50, 200 (1969).
-- -- I. M. Roitt, and D. Doniach: Antibodies to mitochondrial inner membranes in the serum of patients with primary biliary cirrhosis. In: Protides of biological fluids, vol. 15, p. 341. Elsevier Publ. Co. Amsterdam 1967.
—— I. M. Roitt, D. Doniach, and R. W. Horne: Mitochondrial antibodies in primary biliary cirrhosis. III. Characterization of the inner-membrane complement-fixing antigen. Clin. exp. Immunol.4, 511 (1969).
—— —— ——, and H. M. Cooper: Mitochondrial antibodies in primary biliary cirrhosis. IV. Significance of membrane structure for the complement-fixing antigen. Immunology17, 281 (1969).
-- -- -- (1969). V. In Vorbereitung: Studies on the CF-antigen in relation to mitochondria-function.
Bock, H. E.: Hepatitis und posthepatitische Lebererkrankungen. Verh. dtsch. Ges. inn. Med.63, 292 (1957).
Bollag, W.: Nachweis von organspezifischen Antikörpern. Experientia (Basel)12, 210 (1956).
Bothwell, P. W., A. W. Macara, D. Martin, J. F. Skone, and R. C. Wofinden: Infectious hepatitis in Bristol, 1959–1962. Brit. med. J.1963 II, 1613.
Bouchier, I. A. D., K. Rhodes, and S. Sherlock: Serological abnormalities in patients with liver disease. Brit. med. J.1964 I, 592.
Bunker, J. P., et al: (Subcommittee on the National Halothane Study): Summary of the National Halothane Study. J. Amer. med. Ass.197, 775 (1966).
Chappell, J. B.: Systems used for the transport of substrates into mitochondria. Brit. med. Bull.24, 150 (1968).
Chuttani, H. K., A. S. Sidhu, K. L. Wig, D. N. Gupta, and V. Ramalingaswami: Follow-up study of cases from the Delhi epidemic of infectious hepatitis of 1955–1956. Brit. med. J.1966 II, 676.
Cohen, S., G. Ohta, E. J. Singer, and H. Popper: Immunocytochemical study of gamma globulin in liver in hepatitis and postnecrotic cirrhosis. J. exp. Med.111, 285 (1960).
Corridam, M.: The thymus in hepatic cirrhosis. J. clin. Path.16, 445 (1963).
Creutzfeld, W., H. J. Severidt, H. Schmitt, E. Gallasch, H. J. Arndt, H. Brachmann, G. Schmidt u. U. Tschaepe: Untersuchungen über Häufigkeit und Verlauf der ikterischen und anikterischen Transfusionshepatitis. Dtsch. med. Wschr.91, 1813, (1966).
Dacie, J. V.: The haemolytic anaemias: Congenital and acquired, 2nd ed., part 2, The autoimmune haemolytic anaemias. London: J. & A. Churchill 1962.
Dausset, J., J. Colombani, and M. Colombani: Study of leukopenias and thrombocytopenias by the direct antiglobulin consumption test on leukocytes and/or platelets. Blood18, 672 (1961).
Davies, J. S., J. O. Hunt, and A. J. Bovet: Studies on complement effects in a new immune system. J. Immunol.91, 339 (1963).
Deicher, H. R. G., H. R. Holman, and H. Kunkel: Anticytoplasmic factors in the sera of patients with systemic lupus erythematosus and certain other diseases. Arthr. and Rheum.3, 1 (1960).
Dobias, Gy., and M. Balasz: Studies of the pathogenetic role of humoral antibodies reacting with subcellular organ antigens. I. Active Immunization of rabbits with rat organ antigens. II. Passive immunization of rats with anti-rat rabbit immune sera. Immunology12, 373, 389 (1967).
Doniach, D., R. Naccarato, T. Feizi, and S. Sherlock: Family studies in primary biliary cirrhosis. In Vorbereitung 1969.
—— I. M. Roitt, J. G. Walker, and S. Sherlock: Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical applications. Clin. exp. Immunol.1, 237 (1966).
-- J. G. Walker, I. M. Roitt, and P. A. Berg: The concept of an “autoallergic” hepatitis. New Engl. J. Med. (im Druck).
Eyquem, A., et L. Gurow: L'auto-immunité en Hépatologie: l'exploration sérologique par déviation du complement, hémagglutination passive et précipitation. Acta gastro-ent. belg.31, 379 (1968).
Faber, V., and P. Elling: Antinuclear factors in hepatic cirrhosis. Acta path. microbiol. scand.69, 11 (1967).
—— K. Iversen, G. Norup, P. Elling, and H. Poulsen: Serology in hepatic cirrhosis. T. Gastro-ent.7, 245 (1964).
Fernandez-Moran, H.: New approaches in the study of biological ultrastructure by high-resolution. In: The interpretation of ultrastructure, ed. R. J. C. Harris, p. 411. New York: Academic Press 1962.
Fessenden, J. M., and E. Racker: Partial resolution of the enzymes catalyzing oxidative phosphorylation. XI. Stimulation of oxidative phosphorylation by coupling factors and oligomycin inhibition by an antibody against coupling factor 1. J. biol. Chem.241, 2483 (1966).
Fodor, O., et N. Parau: Les facteurs immunosériques non spécifiques dans l'hépatite chronique. Rev. int. Hépat.17, 589 (1967).
Franken, F. H., D. Amelung, P. Garke, D. Pohle, H. Liebermeister u. F. J. Deupmann: Katamnestische Untersuchungen zum Problem der posthepatischen Leberzirrhose. Dtsch. med. Wschr.91, 1753 (1966).
Gajdusek, D. C.: An auto-immune reaction against human tissue antigens in certain acute and chronic diseases. Nature (Lond.)179, 666 (1957).
Gökcen, M.: Autoimmunity in liver disease. J. Lab. clin. Med.59, 533 (1962).
Goudie, R. B., N. M. MacSween, and D. M. Goldberg: Serological and histological diagnosis of primary biliary cirrhosis. J. clin. Path.19, 527 (1966).
Green, D. E., and J. F. Perdue: Correlation of mitochondrial structure and function. Ann. N.Y. Acad. Sci.137/II, 667 (1966).
Hackett, E., M. Beech, and I. J. Forbes: Autoimmune complement-fixation reaction in 1014 patients. Brit. med. J.1960 II, 17.
Harvey, A. M., and L. E. Shulman: Systemic Lupus erythematosus and the chronic biologic false-positive test for Syphilis. In: Lupus erythematosus, by E. L. Dubois, p. 104. New York: McGraw Hill 1966.
Hirayama, C., and T. Toda: Hepatic antigen in sera from patients with liver disease. Nature (Lond.)212, 1061 (1966).
—— K. Tomminage, S. Koga, T. Toda, and N. Murai: Properties of antiliver antibody in sera from patients with liver diseases. Clin. chim. Acta19, 37 (1968).
Holborow, E. J., G. L. Asherson, J. G. Johnson, R. D. S. Barnes, and D. S. Carmichael: Antinuclear factor and other antibodies in the blood and liver disease. Brit. med. J.1963 I, 656.
Ichida, F., H. Sasaki, and G. Wakisaka: Observation on chronic hepatitis in Japan: Morphology, etiology and sequele. In: Progress in liver diseases, vol. 2, p. 416. London: W. Heinemann Medical Books Ltd. 1965.
Ironside, P. N. J., W. G. R. M. de Boer, and R. C. Nairn: Smooth-muscle antibody in lupoid hepatitis. Lancet1966 I, 1210.
Irvine, W. J.: Immunoassay of gastric intrinsic factor and the titration of antibody to intrinsic factor. Clin. exp. Immunol.1, 99 (1966).
Johnson, G. D., E. J. Holborow, and L. E. Glynn: Antibody to smooth muscle in patients with liver disease. Lancet1965 II, 878.
—— —— —— Antibody to liver in lupoid hepatitis. Lancet1966 II, 416.
Joske, R. A., and W. E. King: The LE-cell phenomenon in active chronic viral hepatitis. Lancet1955 II, 477.
Kagawa, Y., and E. Racker: Partial resolution of the enzymes catalysing oxidative phosphorylation. X. Correlation of morphology and function in submitochondrial particles. J. biol. Chem.241, 2475 (1966).
Kaliss, N.: Immunological enhancement: Conditions for its expressions and its relevance for grafts of normal tissues. Ann. N.Y. Acad. Sci.129, 155 (1966).
Kalk, H.: Hepatitis und posthepatitische Leberkrankheiten. Verh. dtsch. Ges. inn. Med.63, 12 (1957).
Kantor, F. S., and G. Klatskin: Serological diagnosis of primary biliary cirrhosis. A potential clue to pathogenesis. Trans. Ass. Amer. Phyens80, 267 (1967).
Klatskin, G.: Subacute hepatic necrosis and postnecrotic cirrhosis due to anicteric infections with the hepatitis virus. Amer. J. Med.25, 333 (1958).
Klingenberg, M., and E. Pfaff: Structural and functional compartmentation in mitochondria. In: Regulation of metabolic processes in mitochondria. BBA Library7, 180 (1966).
Kriss, J. P.: Inactivation of long-acting thyroid stimulator (LATS) by anti-kappa and anti-lambda antisera. J. clin. Endocr.28, 1440 (1968).
Kühn, H. A., u. J. Weinreich: Immunologische Probleme bei chronischer Hepatitis und Leberzirrhose. Dtsch. med. Wschr.89, 723 (1964).
Leddy, J. P.: Immunological aspects of red cell injury in man. In: Seminars in haematology3, 48 (1966).
Lehninger, A. L.: The mitochondrion. Molecular basis of structure and function. New York: W. A. Benjamin, Inc. 1964.
Lerner, R. A., R. J. Glassock, and F. J. Dixon: The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulo nephritis. J. exp. Med.126, 989 (1967).
Licht, W.: Zur Frage leberspezifischer Antigene beim Menschen. Klin. Wschr.44, 833 (1966).
Mackay, I. R.: Lupoid hepatitis and primary biliary cirrhosis: Autoimmune diseases of the liver. Bull. rheum. Dis.18, 487 (1968).
——, and F. M. Burnet: Autoimmune disease, chap. 11. Springfield: Thomas 1962.
——, and D. C. Gajdusek: An “autoimmune” reaction against human tissue antigens in certain acute and chronic diseases. II. Clinical correlations. Arch. intern. Med.101, 30 (1958).
—— —— and L. Larkin: The significance of the presence in human serum of complement-fixing antibodies to human tissue antigens. Aust. Ann. Med.7, 251 (1958).
—— L. I. Taft, and D. C. Cowling: Lupoid hepatitis. Lancet1956 II, 1323.
Maclachlan, M. J., G. P. Rodnan, W. M. Cooper, and R. H. Fennel Jr.: A clinical, serological and pathological study of 20 patients. Ann. intern. Med.62, 425 (1965).
Mahler, H. R., B. Mackler, P. P. Slonimski, and S. Grandchamp: Biochemical correlatives of respiratory deficiency. II. Antigenic properties of respiratory particles. Biochemistry3, 677 (1964).
Martini, G. A., u. W. Dölle: Idiopathische Leberzirrhosen bei Frauen in der Menopause. Klin. Wschr.38, 13 (1960).
McKenzie, J. M.: The long-acting thyroid stimulator: Its role in graves disease. Recent Progr. Hormone Res.23, 1 (1967).
Meyer zum Büschenfelde, K. H.: Untersuchungen über die immunbiologische Bedeutung löslicher Leberprotein. Z. ges. exp. Med.148, 131 (1968).
——, u. C. H. Schwank: Untersuchungen zur Frage organspezifischer Antigene der Leber. Klin. Wschr.44, 654 (1966).
Miescher, P. A., A. Braverman u. E. L. Amorosi: Progressive hypergammablobulinämische Hepatitis. Dtsch. med. Wschr.91, 1525 (1966).
Milgrom, F., Z. Tuggac, and E. Witebsky: Organspecific antigens of liver, testicle and pituitary. J. Immunol.94, 157 (1965).
Moore, F. D.: Orthotopic homotransplantation of the liver looking ahead after the first decade. In: The liver, ed. by A. E. Read, p. 299. London: Butterworth 1967.
Norup, G.: Complement-fixing antibodies. 2. Occurrence in a material of patients with chronic hepatitis. Acta path. microbiol. scand.69, 401 (1967).
Novikoff, A. B.: Mitochondria (chondriosomes). In: The cell: biochemistry, physiology, morphology, ed. by J. Brachet and A. E. Mirsky, vol. 2, p. 299, chap. 5. New York and London: Academic Press 1961.
Palade, G. E.: An electron microscope study of the mitochondrial structure. J. Histochem. Cytochem.1, 188 (1953).
Palakis, E. S., W. Bartley, and G. A. Meek: Changes in the structure and enzyme activity of saccharomyces cerevisiae in response to changes in the environment. Biochem. J.90, 369 (1964).
Paronetto, F., F. Schaffner, R. D. Mutter, J. C. Kniffer, and H. Popper: Circulating antibodies to bile ductular cells in various liver diseases. J. Amer. med. Ass.187, 503 (1964).
—— ——, and H. Popper: Immunocytochemical and serological observations in primary biliary cirrhosis. New Engl. J. Med.271, 1123 (1964).
—— —— —— Antibodies to cytoplasmic antigens in primary biliary cirrhosis and chronic active hepatitis. J. Lab. clin. Med.69, 979 (1967).
Parsons, D. F.: Recent advances correlating structure and function in mitochondria. Int. Rev. exp. Path.4, 1 (1965).
—— G. R. Williams, W. Thompson, and B. Chance: Improvements in the procedure for purification of mitochondrial outer and inner membrane. Comparison of the outer membrane with smooth endoplasmic reticulum. In: Mitochondrial structure and compartmentation, ed. E. Quagliariello, S. Papa, E. C. Slater, J. M. Tager, 29. Bari: Adriatica editrice 1967.
Pasnick, L. J., G. N. Beall, and P. P. Van Arsdel: Complement-fixing reactions with liver tissue in human disease. Amer. J. Med.33, 774 (1962).
Peacock, J. H., and J. Terblanche: Orthotopic homotransplantation of the liver in the pig. In: The liver, ed. by A. E. Read, p. 333. London: Butterworths 1967.
Perlmann, P., S. Hammarsröm, R. Lagercrantz, and D. Campbell: Autoantibodies to colon in rats and human ulcerative colitis: Cross reactivity with escherichia coli 0:14 antigen. Proc. Soc. exp. Biol. (N.Y.)125, 975 (1967).
Pette, D.: Mitochondrial enzyme activities. In: Regulation of metabolic processes in mitochondria. BBA Library7, 28 (1966).
Picken, L. E.: The organization of cells and other organisms, p. 194. London: Oxford University Press 1960.
Podliachouk, L., A. Eyquem et F. Jacqeline: Substances anti-Gm dans les rhumatismes inflammatoires chroniques et dans la cirrhose. Transfusion (Paris)7, 377, (1964).
Polish, E., and L. H. Muschel: Rheumatoid factor and complement-fixing tissue antibodies in patients with liver disease. Amer. J. dig. Dis.7, 677 (1962).
Popper: Persönliche Mitteilung (s. Fußnote 1).
Read, A. E., S. Sherlock, and C. V. Harrison: Active ‘juvenile’ and the effect of corticosteroid therapy. Gut4, 378 (1963).
Rochant, H., A. Gerbal, A. Najman, D. Salmon, F. Gremy, C. H. Salmon et J. Caroli: Analyse des conditions d'apparition des anticorps au cours des cirrhoses hépatiques. Rev. franç. Hémat.7, 415 (1967).
Roitt, I. M., D. Doniach, and C. Shapland: Autoimmunity in pernicious anaemia and atrophic gastritis. Ann. N.Y. Acad. Sci.124, 644 (1965).
Rubin, E., and C. S. Lieber: Alcohol, other drugs and the liver. Ann. intern. Med.69, 1063 (1968).
—— F. Schaffner, and H. Popper: Primary biliary cirrhosis. Chronic non-suppurative destructive cholangitis. Amer. J. Path.46, 387 (1965).
Samloff, I. M., M. S. Kleinman, M. D. Turner, M. V. Sobel, and G. U. Jeffries: Blocking and binding antibodies to intrinsic factor and parietal cell antibody in pernicious anaemia. Gastroenterology55, 575 (1968).
Sargent, A. U., J. Myers, B. Rose, and M. Richter: Organ and species specificity of rat hepatocellular antigens. Immunology10, 199 (1966).
Scheiffarth, F., u. H. Warnatz: Die Pathogenese der chronischen Hepatitis als immunologisches Problem. Klin. Wschr.43, 473 (1965).
Sherlock, S.: Immunological aspects of active chronic hepatitis and primary biliary cirrhosis. Acta gastro-ent. belg.31, 416 (1968).
—— Drugs and the liver. Brit. med. J.1968I, 227.
Shulman, N. R., V. J. Marder, and R. S. Weinrach: Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia or idiopathic purpura. Physiologic, serologic and isotopic studies. Ann. N.Y. Acad. Sci.124, 499 (1965).
Silva, H., E. Hall, K. R. Hill, S. Schaldon, and S. Sherlock: Renal involvement in active ‘juvenile’ cirrhosis. J. clin. Path.18, 157 (1965).
Soergel, K. H., and G. H. Friedell: Nonspecific effects of liver extract-adjuvant injection in guinea pigs. A morphologic and immunologic study. J. Lab. clin. Med.64, 51 (1964).
Sottocasa, G. L., B. Kuylenstierna, L. Ernster, and A. Bergstrand: An electron transport system associated with the outer membrane of liver mitochondria. J. Cell Biol.32, 415 (1967).
Taylor, K. B., I. M. Roitt, D. Doniach, K. G. Couchman, and C. Shapland: Auto-immune phenomena in pernicious anaemia: Gastric antibodies. Brit. med. J.1962II, 1347.
Tobias, H., A. P. Safran, and F. Schaffner: Lymphocyte stimulation and chronic liver disease. Lancet1967I, 193.
Tubbs, P. K., and P. B. Garland: Membranes and fatty acid metabolism. Brit. med. Bull.24, 158 (1968).
Turner, T. B., and R. A. Nelson, Jr.: The relationship of treponemal immobilizing antibody to immunity in syphilis. Trans. Ass. Amer. Phyns63, 112 (1950).
Vogt, P. K.: Die Immunologie der Lebermikrosomen. I. Die Eigenschaften des quantitativen Präzipitinsystems. Z. Naturforsch.15B, 213 (1960).
Vorländer, K. O.: Über den Nachweis komplementbindender Autoantikörper bei Nieren- und Leberkrankheiten. Z. ges. exp. Med.118, 352 (1962).
-- Die Bedeutung der Autoimmunität bei Leberkrankheiten, insbesondere für die chronische Hepatitis. 2. Leber-Symposium in Vulpera, Schweiz, 4. bis 7. april 1965.
Waldenström, J.: Leber, Blutproteine und Nahrungseiweiß. 15. Tagg Dtsch. Ges. Verd. u. Stoffwechselkrankheiten, Bad Kissingen, S. 8 (1950).
Walker, J. G., D. Doniach, and I. Doniach: Mitochondrial antibodies and subclinical liver disease (im Druck).
—— —— I. M. Roitt, and S. Sherlock: Serological tests in diagnosis of primary biliary cirrhosis. Lancet1965I, 827.
—— —— —— —— Immune studies in liver disease. Proc. XIX. Sympos. Colston Res. Soc., Bristol19, 83 (1967).
Warnatz, H., F. Scheiffarth u. R. Schwarz: Tierexperimentelle Untersuchungen zur Pathogenese der chronischen Hepatitis. II. Serologische Studien nach Sensibilisierung mit homologen Leberzellfraktionen. Virchows Arch. path. Anat.339, 364 (1965).
Weiner, W., and G. H. Vos: Serology of acquired hemolytic anemias. Blood22, 606 (1963).
Weir, D. M., E. J. Holborow, and G. D. Johnson: A clinical study of serum antinuclear factor. Brit. med. J.1961I, 933.
Wessler, S.: Primary biliary cirrhosis. J. Amer. med. Ass.206, 1285 (1968).
Whittingham, S., J. Irwin, I. R. Mackay, and M. Smalley: Smooth muscle autoantibody in “Autoimmune” hepatitis. Gastroenterology51, 499 (1966).
—— I. R. Mackay, and J. Irwin: Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet1966I, 1333.
Wiedermann, G., M. Doerner u. P. A. Miescher: Autoimmunitäre Vorgänge gegen Lebergewebe. Schweiz. med. Wschr.94, 257 (1964).
Wiener, A. S., E. B. Gordon, and C. Gallop: Studies on the autoantibodies in human sera. J. Immunol.71, 58 (1953).
Williamson, N., J. Housley, A. Hulme, and P. G. Wall: Autoimmune hepatitis. Lancet1966II, 286.
Author information
Authors and Affiliations
Additional information
Herrn Prof. Dr. Dr. h. c. H. E. Bock zum 65. Geburtstag.
Die im Department of Immunology (Middlesex Hospital, London) durchgeführten Untersuchungen wurden unterstützt von dem Medical Research Council (Great Britain), dem Arthritis and Rheumatism Council, der Nuffield Foundation, der World-Health Organization, der Volkswagenwerk-Stiftung und der Dr. Karl Merck-Stiftung.
Miss Heather Cooper sei an dieser Stelle für die ausgezeichnete technische Hilfe bei der Ausführung des experimentellen Teils dieser Arbeit besonders gedankt.
Rights and permissions
About this article
Cite this article
Berg, P.A., Doniach, D. & Roitt, I.M. Immunologische Phänomene bei Leberkrankheiten: Die Bedeutung mitochondrialer Antikörper. Klin Wochenschr 47, 1297–1307 (1969). https://doi.org/10.1007/BF01484292
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01484292